{"id":200359,"name":"HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)","slug":"horizon-therapeutics-usa-inc-fka-horizon-pharma-usa-inc","state":"IL","country":"United States of America","description":"","totalSpending":33620000,"filings":25,"yearlySpending":[{"year":2018,"income":4210000},{"year":2019,"income":4130000},{"year":2020,"income":5760000},{"year":2021,"income":9480000},{"year":2022,"income":6290000},{"year":2023,"income":3750000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"TAX","display":"Taxation/Internal Revenue Code"},{"code":"GOV","display":"Government Issues"}],"firms":["HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)"],"lobbyists":["BETH RADA","ELI KOGAN","PARUL PATEL","JORDAN CHAPMAN","BRENTON FISK","MATT MCMURRAY"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Office of Policy Development","Executive Office of the President (EOP)","Health & Human Services, Dept of (HHS)","Veterans Affairs, Dept of (VA)","Centers For Medicare and Medicaid Services (CMS)","Treasury, Dept of"],"sampleDescriptions":["Issues related to the implementation of PL 111-148 \"Patient Protection and Affordable Care Act,\" all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and federal program","H.R. 1 \"Tax Cuts and Jobs Act,\" all provisions pertaining to business tax reform.","S 2039 \"Disclosing Foreign Influence Act,\" all provisions pertaining to the LDA filing exemption.","H.R. 1 \"Tax Cuts and Jobs Act,\" all provisions pertaining to business tax reform.","Issues related to the implementation of PL 111-148 \"Patient Protection and Affordable Care Act,\" all provisions pertaining to the Center for Medicare and Medicaid Innovation (CMMI) and federal program"]}